Administration of aerosolized antibiotics in cystic fibrosis patients

Chest

Volumn 120, Issue 3 SUPPL., 2001, Pages 107S-113S

  Moss, R B ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aerosolized antibiotics; Cystic fibrosis; Pseudomonas aeruginosa; Tobramycin solution for inhalation

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; PLACEBO; QUINOLONE DERIVATIVE; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAM NEGATIVE INFECTION; HUMAN; LONG TERM CARE; NEBULIZER; NEPHROTOXICITY; OTOTOXICITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; TREATMENT OUTCOME;

EID: 0034834836     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.3_suppl.107S     Document Type: Article

References (13)

1. Cystic fibrosis
2. Effects of P aeruginosa colonization on lung function and anthropomorphic variables in children with cystic fibrosis
3. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis
4. Effect of high-dose ibuprofen in patients with cystic fibrosis
5. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis
6. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection
7. Ceftazidime in cystic fibrosis: Clinical, microbiological and immunological studies
8. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum
9. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis
10. Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients
11. Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis